The VLC-T32 ?Multidisciplinary Training in Lung Biology? training grant seeks to produce outstanding, independent biomedical scientists who investigate the mechanisms, manifestations, preventions, and cures for lung disorders. The VLC-T32 has established a nationally-recognized track record of training, mentoring, and extensive interactive collaborations between basic science and clinical faculty. This interdisciplinary program is designed both for predoctoral students (N=4) to pursue their PhD degree, and for postdoctoral fellows, either MD/DO or PhD (N=3), to receive an advanced research experience. Mentor-based training is enriched by workshops and didactic courses in advanced contemporary laboratory skills and the ?survival skills? needed to excel in modern academia. Productive mentor-protg interactions are central to the research training experience, and are supplemented by active participation in local and national scientific meetings. Trainee progress is carefully monitored and evaluated by the mentor(s), the program PIs and Co-Directors, the Mentoring Council (Executive Committee), and the VLC-T32 Steering Committee. The faculty participating in this program have been chosen on the basis of research productivity, significant grant support, collegiality, and commitment to serve as outstanding mentors. The unique science research focus areas of the program include pulmonary mechanics, airway epithelial biology, inflammation, oxidative chemistry, immune responses, lung repair and regeneration, metabolism, cell apoptosis, and cell signaling. Additionally, clinical patient-oriented research focuses on asthma, interstitial lung disease, cystic fibrosis, acute lung injury, obesity, cell therapy, lung infections, ICU nutrition, palliative care in a rural setting, and health care policy. The disciplines of pulmonary medicine, pathology, bioengineering, microbiology, pathology, immunology, physiology, and public health are strongly represented. Although the trainee will receive intensive training in a single area of research, they will also receive broad-based exposure to lung-related research in complementary disciplines. Patient-oriented and translational research is stressed within and throughout the program.
The aims of the VLC-T32 are to provide training in the 1) technical (application of rigorous, ethical, transparent and quantitative methods to the study of well-posed scientific questions in lung biology and disease), 2) operational (basic, translational and clinical research methods that fosters the development of an inclusive and interdisciplinary team-oriented environment), and 3) professional (mentoring and ongoing career evaluation) skills that will enable those supported to develop successful, research-intensive careers. A strength of the program is the collaborative environment and interactive relationships in which clinicians and basic science investigators integrate to forge productive team science that is the basis of modern biomedical research. The VLC-T32 will be regularly evaluated by an independent advisory committee. Finally, this program has strong institutional support from UVM, and will allow us to continue training young investigators to become future national/international leaders in pulmonary research.

Public Health Relevance

Lung disease is devastating, and its prevalence and resulting deaths are both increasing. This training program for predoctoral and postdoctoral researchers seeks to train a group of collaborative and productive scientists to investigate the causes, diagnosis, and cures of debilitating lung diseases such as asthma, interstitial lung disease, cystic fibrosis, acute lung injury, and infections of the lung.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
2T32HL076122-16
Application #
9631607
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Kalantari, Roya
Project Start
2004-04-01
Project End
2024-04-30
Budget Start
2019-05-01
Budget End
2020-04-30
Support Year
16
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Willsey, Graham G; Ventrone, Sebastian; Schutz, Kristin C et al. (2018) Pulmonary Surfactant Promotes Virulence Gene Expression and Biofilm Formation in Klebsiella pneumoniae. Infect Immun 86:
Hamlington, Katharine L; Bates, Jason H T; Roy, Gregory S et al. (2018) Alveolar leak develops by a rich-get-richer process in ventilator-induced lung injury. PLoS One 13:e0193934
Hamlington, Katharine L; Smith, Bradford J; Dunn, Celia M et al. (2018) Linking lung function to structural damage of alveolar epithelium in ventilator-induced lung injury. Respir Physiol Neurobiol 255:22-29
Dutmer, Cullen M; Schiltz, Allison M; Freeman, Kristy L et al. (2018) Observed Home Dampness and Mold Are Associated with Sustained Spikes in Personal Exposure to Particulate Matter Less than 10 ?m in Diameter in Exacerbation-Prone Children with Asthma. Ann Am Thorac Soc 15:S131-S132
King, Benjamin R; Samacoits, Aubin; Eisenhauer, Philip L et al. (2018) Visualization of Arenavirus RNA Species in Individual Cells by Single-Molecule Fluorescence In Situ Hybridization Suggests a Model of Cyclical Infection and Clearance during Persistence. J Virol 92:
Ziegler, Christopher M; Bruce, Emily A; Kelly, Jamie A et al. (2018) The use of novel epitope-tagged arenaviruses reveals that Rab5c-positive endosomal membranes are targeted by the LCMV matrix protein. J Gen Virol 99:187-193
Qian, Xi; Aboushousha, Reem; van de Wetering, Cheryl et al. (2018) IL-1/inhibitory ?B kinase ?-induced glycolysis augment epithelial effector function and promote allergic airways disease. J Allergy Clin Immunol 142:435-450.e10
Heppner, David E; Hristova, Milena; Ida, Tomoaki et al. (2018) Cysteine perthiosulfenic acid (Cys-SSOH): A novel intermediate in thiol-based redox signaling? Redox Biol 14:379-385
Anathy, Vikas; Lahue, Karolyn G; Chapman, David G et al. (2018) Reducing protein oxidation reverses lung fibrosis. Nat Med 24:1128-1135
Heppner, David E; Dustin, Christopher M; Liao, Chenyi et al. (2018) Direct cysteine sulfenylation drives activation of the Src kinase. Nat Commun 9:4522

Showing the most recent 10 out of 99 publications